BMS 905 is a novel and potent Dual Antagonist of Toll-like Receptors 7 and 8 (TLR7/8),Control of this unintended activation via inhibition of TLR7/8 signaling holds promise for the treatment of diseases such as psoriasis, arthritis, and lupus.